New combo treatment aims to restore color in resistant vitiligo patches

NCT ID NCT07352293

Recruiting now Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

First seen Jan 24, 2026 · Last updated May 21, 2026 · Updated 19 times

Summary

This study tests whether adding a 6-month course of methotrexate improves the results of a skin cell transplant (NCES) for adults with stable, hard-to-treat vitiligo on elbows and knees. Twenty participants will be split into two groups: one gets methotrexate before and after the transplant, the other gets the transplant alone. Both groups also receive light therapy (PUVA) for 3 months after the procedure. The goal is to see if the combination leads to better repigmentation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VITILIGO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Dermatology Outpatient Clinic, Kasr al Ainy Teaching Hospital, Cairo University
RECRUITING

Cairo, Egypt

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

VITILIGO